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Background: There is debate around the composition of life years gained from smoking elimination. The aim of
this study was to conduct a systematic review of the literature to synthesize existing evidence on the effect
of smoking status on health expectancy and to examine whether smoking elimination leads to compression of
morbidity. Methods: Five databases were systematically searched for peer-reviewed articles. Studies that pre-
sented quantitative estimates of health expectancy for smokers and non-/never-smokers were eligible for inclu-
sion. Studies were searched, selected and reviewed by two reviewers who extracted the relevant data and
assessed the risk of bias of the included articles independently. Results: The search identified 2491 unique records,
whereof 20 articles were eligible for inclusion (including 26 cohorts). The indicators used to measure health
included disability/activity limitations (n¼9), health-related quality of life (EQ-5D) (n¼2), weighted disabilities
(n¼1), self-rated health (n¼9), chronic diseases (n¼6), cardiovascular diseases (n¼4) and cognitive impairment
(n¼1). Available evidence showed consistently that non-/never-smokers experience more healthy life years
throughout their lives than smokers. Findings were inconsistent on the effect of smoking on the absolute number
of unhealthy life years. Findings concerning the time proportionally spent unhealthy were less heterogeneous:
nearly all included articles reported that non-/never-smokers experience relatively less unhealthy life years (e.g.
relative compression of morbidity). Conclusions: Support for the relative compression of morbidity due to smok-
ing elimination was evident. Further research is needed into the absolute compression of morbidity hypothesis
since current evidence is mixed, and methodology of studies needs to be harmonized.
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Introduction
W
orldwide life expectancies are increasing, which is partly the
result of new medical possibilities. We live longer, but the
burden of non-communicable diseases (NCD) has never been
higher. NCDs are currently the leading cause of deaths worldwide.1
The majority of these NCDs may be the consequence of modifiable
lifestyle risk factors, such as smoking, physical inactivity, excessive
alcohol consumption and poor diet.2 The exact influence of preven-
tion of lifestyle risk factors on longevity and health, including the
number of life years spent in good or impaired health, remains
unclear. This is in particular the case for smoking.
The past decade can be described as a public health success story
in terms of smoking prevalence reduction. Joint efforts have led to
substantial decreases in tobacco consumption worldwide. However,
smoking is still considered as a major public health threat and this is
recognized by several initiatives that aim to combat this threat. A
main initiative is the world’s first public health treaty: the World
Health Organization (WHO) Framework Convention for Tobacco
Control, which is as of 2016 ratified by 180 parties.3 Strengthening
its implementation is also mentioned in the United Nations’
Sustainable Development Goals.4 Another explicit goal set by the
WHO involves the 2525 NCDs targets, which include lowering
tobacco use by 30% between 2010 and 2025.5
There is a debate around the composition of life years gained
from smoking elimination. A reduction in smoking prevalence leads
to higher life expectancies because of the effect of smoking on mortality
through fatal diseases.1 However, smoking also has an effect on morbid-
ity through a wide range of both fatal and non-fatal diseases.6 Which
effect is stronger, the morbidity or mortality effect, will determine how
these life years are spent. A reduction in smoking prevalence may lead to
either a compression of morbidity,7 an expansion of morbidity,8 or a
dynamic equilibrium,9 implying, respectively, that less smoking leads to
fewer years lived with morbidity, more years lived with morbidity, or to a
shift from more severe to less severe morbidity. The third theory, a
dynamic equilibrium, has never been formally defined. Morbidity and
disability here not binary but are more considered as processes and
therefore often proposed as the ‘intermediate’ scenario between the other
two theories.10 Hence, in this study, we merely focus on the first two
theories. Consequences on morbidity can be examined as absolute and
relative effects.11 The absolute effects reflect the change of number of
years lived unhealthily. When this change is interpreted as a percentage
change, we consider the consequences as relative effects.12 On the indi-
vidual level, distinguishing between the absolute and relative effects are
not per se of an added value. However, the absolute and relative changes
are both relevant to capture and estimate changes in population health.
The increased efforts that are undertaken to lower smoking prev-
alence’s emphasize the need to understand the impact of smoking
elimination on population health. This study aims to conduct a
systematic literature review in order to synthesize existing know-
ledge on the effect of smoking status on health expectancy. Health
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years lived in good health and years lived in poor health (in absolute
terms and as proportion of total lifetime)10,13 and thus allows us to
assess whether non-smokers experience a compression of morbidity




Four databases were systematically searched for peer-reviewed stud-
ies from inception up to July 2018: Embase.com (since 1971),
Medline ALL via Ovid (since 1946) Web of Science Core
Collection (since 1975), Cochrane Central Register of Trials via
Wiley (since 1992). An additional search was performed in Google
Scholar. This search engine could help in retrieving articles that have
not been published yet or had no relevant search terms in their title
and abstract. The search equation combined search terms (using
thesaurus terms when available combined with terms in title and/
or abstract) for ‘smoking’ and ‘health status indicators’. We adopted
a broad search strategy to cover a wide spectrum of articles. The
search strategy was set up together with a librarian. The complete
search strategies for all databases can be found in Supplementary file
S1.
Eligibility criteria
We included articles based on the following eligibility criteria:
(1) The article focuses on smoking and health expectancy.
(2) The article estimates health expectancy for smokers and non-
smokers, either prospectively or retrospectively.
(3) The article focuses on a sample that aims to be representative for
the general population.
(4) The article is written in English.
(5) The article is not a conference abstract, letter, note or editorial.
Health status indicators can range from objective measures (e.g.
disease status) to subjective measures (e.g. self-perceived health). We
did not limit inclusion by a certain type of health status indicator.
Selection strategy
Two researchers screened the retrieved articles. The predefined eli-
gibility criteria guided the decision process for inclusion and exclu-
sion. When the information provided in the titles and abstracts were
insufficient for a decision, a brief screening of the full-text took place
to decide whether the article was eligible for inclusion. Differences in
screening results, among the two researchers, were discussed and
resolved by dialogue. When no consensus could be achieved, a third
researcher was consulted to judge. Study selection was conducted in
Endnote X6.
Data extraction
Extraction forms were developed to assist in the harmonization of
the extracted data. Extracted data included the following informa-
tion: operationalization of exposure and outcome variables, study
population characteristics, applied method to estimate health ex-
pectancy and the health expectancies. Two main approaches for
the estimation of health expectancy exist, which can be applied ei-
ther on cross-sectional or longitudinal data.14 Prevalence-based life
tables, also known as Sullivan’s Method, is applied on cross-
sectional data.15 The other approach uses multiple measurements
and is based on incidence rather than prevalence and often relies on
the multi-state life tables.16 The risk of bias was assessed with a
quality assessment tool for observational cohort and cross-
sectional studies (Supplementary files S2 and S3).
Data analysis
The study selection was reported according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) (figure 1).17 For all studies it was evaluated whether a
compression or expansion of morbidity (both in relative and abso-
lute terms) occurred by comparing the findings between non-/
never-smokers and current smokers.11 An absolute expansion of
morbidity indicates an increase in the number of unhealthy life years
for non-/never-smokers. This may lead to either an increase or de-
crease in the proportion of life spent in poor health for non-/never-
smokers: relative compression or expansion of morbidity.
Results
Study search
Figure 1 shows the PRISMA flow diagram of the screening process.
In total, 2488 unique records were identified and screened. We
excluded 2367 articles based on title and abstract. Thus, the full-
text of 121 articles were assessed of which, we excluded 101 articles
most of including no relevant outcomes. Moreover, one study
reported health expectancies where the unhealthy and healthy life
years did not add up to the total life expectancy. It was decided to
exclude this article due to inadequate results. This resulted in 20
included articles. Some articles reported health expectancies for
multiple population cohorts: in total health expectancies for 26
population cohorts were reported. The quality assessment
(Newcastle—Ottawa quality assessment), independently conducted
by two researchers, showed that the majority of the articles were of
sufficient quality (scoring at least five out of the eight stars). One
article18 showed some reason for concern with scoring three stars
because the study did not control for factors in the analysis.
Study characteristics
Table 1 provides characteristics of the included articles (N¼ 20),
listed by cohort (N¼ 26). The first column in table 1 attaches a
number to each cohort. These numbers will be used for reference
in the rest of this article. Data collection of the population cohorts
occurred between 1948 and 2014. Sample sizes varied from 1759 up
to 42 516 respondents. Smoking status was defined in various man-
ners, namely in two categories [(ever)smokers, non-/never-smok-
ers]; three categories (current smokers, former smokers and never-
smokers); or four categories (heavy smokers, moderate smokers,
former smokers and never-smokers). The studies that applied a di-
chotomous definition for smoking status could still vary by group
composition due to the categorization of former smokers. The indi-
cators for health involved disability/activity of daily living limita-
tions (n¼ 9), health-related quality of life (EQ-5D) (n¼ 2),
disability weights (n¼ 1), self-rated health (SRH) (n¼ 9), chronic
diseases (n¼ 6), cardiovascular diseases (n¼ 4) and cognitive im-
pairment (n¼ 1). Some studies estimated health expectancies for
different indicators for health, e.g. for both SRH and chronic dis-
eases. The majority of the studies (n¼ 11) used a longitudinal ap-
proach by applying a multi-state (Markov) transition model. The
Sullivan approach (cross-sectional data) was the other main applied
method (n¼ 6). More novel methods were applied by Van Baal
et al.19 and Mehta and Myrskylä.20The former adopted a dynamic
population model (RIVM chronic disease model) whereas the latter
applied a matrix population model (an extension of the multi-state
technique).
Compression of morbidity hypothesis
In order to assess the occurrence of compression of morbidity, we
compared the unhealthy life years between non-/never-smokers and
current smokers. Supplementary file S4 shows the health expectan-
cies (unhealthy life years þ healthy life years ¼ life expectancy) of






/eurpub/advance-article/doi/10.1093/eurpub/ckaa235/6041769 by guest on 18 January 2021
the included articles. Table 2 shows the answers on the question
whether a compression of morbidity was observed in the health
expectancies. The different starting ages for the health expectancy
estimations are also included in the table. The heterogeneity in the
data (different health indicators, different starting ages, different
smoking definitions and further stratification) hampered direct
comparisons between studies. Nonetheless, we grouped the health
indicators into three categories (disability, SRH and longstanding
illness) in order to structure the findings and gain insights.
The results for the absolute compression of morbidity hypothesis
are diffuse: approximately half of the studies reported an absolute
compression of morbidity. This means that non-/never-smokers
spent less time in poor health. Yet, this also indicates that approxi-
mately half of the studies found that non-/never-smokers spent a
longer time in poor health than current, moderate and heavy smok-
ers (absolute expansion of morbidity). This last finding was mostly
found in studies that applied disability as an indicator for health.
Most of the studies reported a relative compression of morbidity
[except cohorts #7, #8, #26 (women), #11 (men), #19 (only from
80 years), #1]. The studies that did not report a relative compression
of morbidity (and thus found a relative expansion of morbidity)
were prevalent in all three health categories. Further, a finding was
that all studies reported that non-/never-smokers have more healthy
life years compared to smokers.
Health expectancies—disability
Figure 2 shows the health expectancies of the studies that are listed
under the disability category in table 2. The studies #6, #8, #9 and
#25 are not included in this figure because they are further stratified
(#8) or have the EQ-5D or disability weights as health indicator.
This figure is only reported for this measure due to the great vari-
ability between the studies. The numbers in the bars indicate the
healthy and unhealthy life years.
For men, the differences in unhealthy life years between non-/
never-smokers and current smokers varied between 0.3 years and
þ1.3 years. Most studies (n¼ 8) found more unhealthy life years for
non-/never-smokers, indicating an absolute expansion of morbidity.
For example, in cohort #12 it was found that non-/never-smokers
would have 4.6 unhealthy life years, while current smokers would
only have 3.8 unhealthy life years. The relative differences are hard
to observe from this figure, but these can be found in
Supplementary file S4. Most studies show a relative compression
of morbidity, except cohorts #7 and #11.
For women, the same pattern was observed. However, the differ-
ences in the number of unhealthy life years between non-/never-
smokers and current smokers were larger, ranging from -1.1 years
to 2.4 years. For instance, in cohort #2, it was estimated that smokers
would have 13.4 unhealthy life years while non-/never-smokers
would have 15.8 unhealthy life years. A relative compression of
morbidity was also found for women in most studies, except in
the cohorts #7 and #26. Moreover, figure 2 shows that women
have on average a higher total life expectancy and more unhealthy
life years compared to men.
Discussion
While health expectancies are central in the debate related to quan-
tity vs. quality of life, a relatively small number of studies have
investigated the health expectancies for smokers and non-/never-
smokers. This systematic review extracted 20 articles from the
2488 unique retrieved records. Within these 20 articles, a total of
26 cohorts were studied. Our collected evidence showed consistently
that non-/never-smokers spent more years in good health through-
out their lives than smokers. In contrast, findings were inconsistent
regarding the effect smoking has on the absolute number of un-
healthy life years. Estimates for unhealthy life years were diffuse
for all applied health indicators. Approximately half of the studies
found an absolute compression of morbidity for non-/never-smok-
ers compared to smokers. As such, the other half of the studies
reported an absolute expansion of morbidity, which is a finding
that deserves attention in this discussion. Findings concerning the
time proportionally spent unhealthy were less heterogeneous: nearly
all included articles reported relative compression of unhealthy life
years for non-/never-smokers compared to smokers. Caution in
drawing universal conclusions of our findings is required because
of the heterogeneity in the studies.
Chronic diseases mostly have an onset earlier in life than disabil-
ities, however, the mortality effect of chronic diseases is reduced
nowadays. Hence, life years after the onset of chronic diseases are
likely to exceed life years after the onset of disabilities. Smokers may
not reach the average age at which severe disabilities [e.g. Activities
Figure 1 Flow diagram
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2. NPHS Canada 1994–96 8009 Non-smokers (never
smoked, stopped
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3. DANCOS Denmark 1991, 1994 5811 Never-smokers, former
smokers, moderate
smokers (1–14 g tob.
p/d), heavy smokers








4. DANCOS Denmark 2000 16 690 Never-smokers, former
smokers, moderate
smokers (1–14 g tob.
p/d), heavy smokers






5. DANCOS Denmark 2000 16 690 Never-smokers, moder-
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6. DANCOS Denmark 2000 12 524 Never-smokers, former
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7. EPESE USA 1981–89 8604 Never-smokers, former
smokers,
current smokers
(note: in most analyses
past and current as
single group)
Activities of daily living
(walking across a
small room, trans-
ferring from bed to
chair, bathing, dress-
ing, eating, groom-





8. EPESE USA 1981–89 3673 Never-smokers, former
smokers,
never-smokers
Activities of daily living
(walking across a
small room, trans-
ferring from bed to
chair, bathing, dress-
ing, eating, groom-
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10. POLS The Netherlands 1997, 1999 6446 Never-smokers, former
smokers, current
smokers
Disability (to walk up
and down the stairs,
walk outside, enter/
leave the house, sit
down/get up from a
chair, move around
on the same floor,
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of daily living (ADL)] become relevant, which might explain the
reported relative small differences in unhealthy life years between
non-/never-smokers and smokers. Some included articles analyzed
SRH and chronic diseases for the same study population (cohorts
#3, #21, #22, #23 and #24). In the majority of these cohorts the
largest differences between smokers and non-/never-smokers were
found for health expectancies estimated with SRH. Three of the

















11. ECHP Western Europec 1998–2001 66 331 Never-smokers,
daily smokers
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12. HRS USA 1998–2012 14 804 Never-smokers,
ever smokers
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USA 1948–89 4634 Never-smokers, former
smokers, current
smokers







15. RCPH Denmark 1982–94 1759 Never-smokers, former
smokers, current
smokers






et al.)3316. ESTHER Germany 2000–10 8482
17. Tromso Norway 1994–2001 9179














USA 1992–2004 16 176 Never-smokers, former
smokers, current
smokers
















et al.)3622. FPS Finland 1997–2013 42 516
23. GAZEL France 1996–2014 14 931
24. SLOSH Sweden 2006–14 8118
25. Multiple
sourcesd

















26. BHIS Belgium 1997, 2001, 2004 17 148 Never-smokers, daily
smokers
Activities of daily liv-
ing; mobility limita-
tions (transferring











a: Time period included in article.
b: At baseline; n.s. ¼ not stated.
c: Nine countries: Finland, Denmark, Ireland, Austria, Belgium, Greece, Italy, Spain and Portugal.
d: Different sources were used: Dutch Burden of Disease Study, GP registrations, national registries and population surveys (STIVORO,
POLS).
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Table 2 Compression of morbidity hypothesis overview included articles
Compression of morbidity?
#a Health indicator NS–CS NS–MS NS–HS
Absolute Relative Absolute Relative Absolute Relative
Disability
7.b,c ADL M 65: No 65: No NA NA NA NA
F 65: No 65: No NA NA NA NA
8.c ADL M 65: No 65: No NA NA NA NA
70: No 70: No NA NA NA NA
75: No 75: No NA NA NA NA
80: No 80: No NA NA NA NA
85: No 85: No NA NA NA NA
Low educated 90: No 90: No NA NA NA NA
F 65: No 65: No NA NA NA NA
70: No 70: No NA NA NA NA
75: No 75: No NA NA NA NA
80: No 80: No NA NA NA NA
85: No 85: No NA NA NA NA
90: No 90: No NA NA NA NA
ADL M 65: No 65: No NA NA NA NA
70: No 70: No NA NA NA NA
75: No 75: No NA NA NA NA
80: No 80: No NA NA NA NA
85: No 85: No NA NA NA NA
High educated 90: No 90: No NA NA NA NA
F 65: No 65: No NA NA NA NA
70: No 70: No NA NA NA NA
75: No 75: No NA NA NA NA
80: No 80: No NA NA NA NA
85: No 85: No NA NA NA NA
90: No 90: No NA NA NA NA
26. ADL & mobility limitations M 15: No 15: Yes NA NA NA NA
F 15: No 15: No NA NA NA NA
12. Katz ADL M 50: No 50: Yes NA NA NA NA
F 50: No 50: Yes NA NA NA NA
20.c Katz ADL M 55: No 55: Yes NA NA NA NA
F 55: No 55: Yes NA NA NA NA
2. ADL & dependency M 45: No 45: Yes NA NA NA NA
F 45: No 45: Yes NA NA NA NA
6.c EQ-5D M NA NA 25: Yes 25: Yes 25: Yes 25: Yes
F NA NA 25: Yes 25: Yes 25: Yes 25: Yes
9. EQ-5D M 18: Yes 18: Yes NA NA NA NA
F 18: Yes 18: Yes NA NA NA NA
10.c Disability M 55: No 55: Yes NA NA NA NA
F 55: Equal 55: Yes NA NA NA NA
11.d Disability M 16: No 16: No NA NA NA NA
F 16: Yes 16: Yes NA NA NA NA
13. Disability M 30: Yes 30: Yes NA NA NA NA
70: Yes 70: Yes NA NA NA NA
F 30: Yes 30: Yes NA NA NA n.a
70: Yes 70: Yes NA NA NA NA
25. Disability weights M 20: Yes 20: Yes NA NA NA NA
40: Yes 40: Yes NA NA NA NA
60: Yes 60: Yes NA NA NA NA
F 20: No 20: Yes NA NA NA NA
40: No 40: Yes NA NA NA NA
60: Yes 60: Yes NA NA NA NA
SRH
18.c SRH M 50: No 50: Yes NA NA NA NA
55: No 55: Yes NA NA NA NA
60: Yes 60: Yes NA NA NA NA
F 50: Yes 50: Yes NA NA NA NA
55: No 55: Yes NA NA NA NA
60: No 60: Yes NA NA NA NA
19.c SRH M 70: No 70: Yes NA NA NA NA
75: Yes 75: Yes NA NA NA NA
80: No 80: No NA NA NA NA
F 70: Equal 70: Yes NA NA NA NA
75: Yes 75: Yes NA NA NA NA
80: No 80: No NA NA NA NA
21. SRH M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
22. SRH M 50–75: Yes 50–75: Yes NA NA NA NA
(continued)
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diseases, while none of these studies reported that male smokers had
less years in poor SRH. Put differently, health expectancy measured
with SRH resulted in fewer healthy life years and more unhealthy life
years for smokers compared to health expectancy estimated with
chronic diseases. This could be because chronic diseases are stronger
associated with mortality than SRH. Further, one study in our re-
view had cognitive impairments as an indicator for health and
reported absolute and relative expansion of morbidity for non-
smokers. This health measure deviates from the other included
health indicators but is an important health indicator in an aging
population. Hence, the effect of smoking elimination on this health
indicator is worth further exploring.
From a methodological perspective, studies differed considerably.
Firstly, remaining health expectancies were estimated from a variety
of ages. Health expectancy estimations from an older age (e.g.
65 years) are likely to underestimate the effect of smoking since
premature deaths and early onset of reduced health are not cap-
tured. In total, eleven cohorts estimated health expectancy with a
start age of 65 years and higher of which, seven cohorts reported
absolute expansion of morbidity and five cohorts a relative expan-
sion of morbidity. Secondly, various categorizations for smoking
were applied. Respondents belonging to a never/non-smoking group
could differ from studies with a category for former smokers.
Thirdly, estimation methods for health expectancy were character-
ized by the Sullivan’s method or the multi-state life table method.
The multi-state life table method provides a richer analysis, but for
health expectancy estimations, it is suggested that Sullivan’s method
is easier to implement and needs less assumptions.38 Fourthly, stud-
ies used different methods to measure health status. Questionnaires,
interviews, health care professionals and other sources were used.
Strengths and limitations
The discussed variety of methods hampered comparability and in-
terpretation of the results. A meta-analysis was therefore not pos-
sible. Health expectancy as a measure for population health has
become a standard. A call for adopting a homogeneous measure
of health expectancy has frequently been made.39 A strength of
this systematic review was the applied search strategy, which was
comprehensive and covered a variety of databases and the consult-
ation of experts. This creates confidence that we reached the most
relevant published articles. All retrieved articles were independently
double screened, and the data were extracted independently.
Table 2 Continued
Compression of morbidity?
#a Health indicator NS–CS NS–MS NS–HS
Absolute Relative Absolute Relative Absolute Relative
F 50–75: Yes 50–75: Yes NA NA NA NA
23. SRH M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
24. SRH M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
3.c SRH M NA NA 20: Yes 20: Yes 20: Yes 20: Yes
NA NA 65: Yes 65: Yes 65: Yes 65: Yes
F NA NA 20: Yes 20: Yes 20: Yes 20: Yes
NA NA 65: No 65: Yes 65: Yes 65: Yes
4.c SRH M NA NA 30: Yes 30: Yes 30: Yes 30: Yes
F NA NA 30: Yes 30: Yes 30: Yes 30: Yes
5.b SRH M NA NA 30: Yes 30: Yes 30: Yes 30: Yes
F NA NA 30: Yes 30: Yes 30: Yes 30: Yes
Longstanding illness
21. Longstanding illness M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
22. Longstanding illness M 50–75: No 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
23. Longstanding illness M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
24. Longstanding illness M 50–75: Yes 50–75: Yes NA NA NA NA
F 50–75: Yes 50–75: Yes NA NA NA NA
3.c Longstanding illness M NA NA 20: No 20: No 20: Yes 20: Yes
NA NA 65: No 65: No 65: No 65: Yes
F NA NA 20: No 20: No 20: Yes 20: Yes
NA NA 65: No 65: No 65: Equal 65: Yes
4.c Longstanding illness M NA NA 30: No 30: Yes 30: Yes 30: Yes
F NA NA 30: No 30: Yes 30: No 30: No
1. Cognitive impairment M 65: No 65: No NA NA NA NA
F 65: No 65: No NA NA NA NA
14.c Cardiovascular disease M 50: No 50: Yes NA NA NA NA
F 50: No 50: Yes NA NA NA NA
15.c Cardiovascular disease M 50: No 50: Yes NA NA NA NA
F 50: No 50: Yes NA NA NA NA
16.c Cardiovascular disease M 50: Yes 50: Yes NA NA NA NA
F 50: Yes 50: Yes NA NA NA NA
17.c Cardiovascular disease M 50: Yes 50: Yes NA NA NA NA
F 50: Yes 50: Yes NA NA NA NA
a: Corresponds with the cohort # in table 1.
b: Middle educational level.
c: Reports former smokers separately.
d: Normal body weight. NS, non/never-smoker; CS, current smoker; MS, moderate smoker; HS, heavy smoker; M, male; F, female.
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Conclusion
When a reduction in smoking prevalence delays both death and ill
health, relative and absolute time spent unhealthily may still in-
crease.40 Relative compression of morbidity due to smoking elimin-
ation was found in most of the studies. Further research is needed to
examine the effect of smoking elimination on the absolute number
of years spent unhealthily since findings were mixed in all health
categories. The health indicators for health expectancy should be
more streamlined in future research to synthesize and understand
the implications of smoking elimination on population health
better.
The support found in approximately half of the studies for abso-
lute expansion of morbidity for non-/never-smokers raises questions
concerning the related consequences for public health. When society
will be smoke-free, health expectancies change and thus the envir-
onment need to adapt accordingly to cope with this change. Health
systems might be in need for specific adaptations in order to deal
with people spending more years unhealthily. For instance, disease
management programs with a particular focus on the most common
NCDs will become more important.41
Supplementary data
Supplementary data are available at EURPUB online.
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